Abstract:HepatoBiliary Surg Nutr 2021 | https://dx.doi.org/10.21037/hbsn-21-365 Colorectal liver metastases (CRLM) are one of the most frequent clinical conditions. Over the last 20 years, the clinical outcome for patients with CRLM has improved greatly. Liver resection is the gold standard treatment for resectable CRLM, achieving a 5-year overall survival (OS) rate of 42% (1). However, the majority of patients with CRLM are not candidates for resection. With the development of thermal ablation, this technique provides an alternative treatment modality by either ablation alone or combined with resection. A recent review by Takahashi et al. summarized the current role of thermal ablation in the management of CRLM (2). In this review, the authors stated that ablation should not be used in lieu of liver resection for resectable CRLM based on current available evidence. Regarding the rapid advancement of systemic and local therapy, the treatment strategies for patients with CRLM are suggested to be discussed by the multidisciplinary team (MDT). Also, the authors listed the indications of ablation in their center, including unresectable liver lesions (tumor number ≤8, tumor size ≤4 cm), combined with hepatectomy, and resectable liver lesions but patients unfit to receive resection because of comorbidities and patient preference. These indications are highly feasible and can be referred by readers. It is noteworthy that the preferred tumor size and number were inconsistent in the light of the clinician’s experience. In general, thermal ablation is recommended for tumor size ≤3 cm. For tumor size between 3 and 5 cm, welllocated tumors can also be effectively treated depending on anatomical position and the treatment protocol used (3). Tumor number varies from 5 to 9 in the literature, which depends on the total liver tumor volume. The authors then pointed out the pros and cons of 3 approaches to perform ablation. Open and laparoscopy approaches allow better staging for occult liver metastases or peritoneal disease and protect surrounding organs from thermal injuries. It has been reported that additional metastases were detected in 10–25% of patients with CRLM by intraoperative ultrasound (4), which may result in changing the surgical strategy. The percutaneous approach provides the least invasive approach and has a significant role in patients with limited recurrent liver metastases after resection or ablation. Moreover, percutaneous ablation can be used as the ‘test-of-time’ approach reported by Livraghi et al. (5). The rationale of this approach is: (I) high technical success rate of ablation for small tumors without the need for resection; (II) if ablation was unsuccessful, the resection was still feasible; (III) if patients develop additional lesions after ablation and would no longer be suitable for resection, they can be spared unnecessary surgery. Among the 88 patients treated in the study by Livraghi et al. (5), 26% remained free of disease without the need for resection, 24% underwent resection after ablation, and 50% were unfit for resection due to disease progression. Compared with liver resection, local tumor recurrence (LTR) is a major issue after ablation. Predictors of LTR include tumor size ≥3 cm and ablation margin ≤0.5 cm. In Editorial

Standardization of Thermal Ablation in Treatment of Liver Tumor

Thermal ablation for hepatic tumors in high-risk locations

Prevention and Treatment of Major Complications in Liver Cancer Patients after Thermal Ablation

[The Importance of Image Guided Radiofrequency Ablation with Standard Treatment Strategy for Liver Malignancies].

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma

Progress in Ablation Therapy of Liver Cancer

Chinese Expert Consensus on Co-Ablation System for the Treatment of Primary Liver Cancer(2023 Edition)

Application of Thermal Ablation in Patients with Primary Hepatic Carcinoma and its Cognition from Physicians and Managers

[Efficacy of Radiofrequency Ablation of 343 Patients with Hepatic Tumor and the Relevant Complications].

Treatment Strategy to Optimize Radiofrequency Ablation for Liver Malignancies.

A New Local Ablation for Unresectable Primary Liver Tumor: Effect of Electrothermal and Electrochemical Therapy on Rat Liver

The Progress of Radiofrequency Ablation for the Treatment of Liver Cancer

The Current Application of Thermal Ablation in Colorectal Liver Metastasis.

Treatment Efficacy of Radiofrequency Ablation of 338 Patients with Hepatic Malignant Tumor and the Relevant Complications.

Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns

Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles

Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours

The latest research progress on minimally invasive treatments for hepatocellular carcinoma

Radiofrequency Ablation in Treatment of Malignant Liver Tumors

Progress of Ultrasound-Guided Radiofrequency Ablation of Hepatocellular Carcinoma in Difficult Areas

Strategy radiofrequency ablation for treatment of refractory liver cancer